Stephens Investment Management Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$68.8M Sell
604,813
-2,409
-0.4% -$274K 0.91% 42
2025
Q1
$63.8M Sell
607,222
-5,560
-0.9% -$585K 0.92% 36
2024
Q4
$65.7M Sell
612,782
-5,914
-1% -$634K 0.88% 38
2024
Q3
$61.9M Sell
618,696
-33,304
-5% -$3.33M 0.84% 46
2024
Q2
$54.9M Sell
652,000
-44,758
-6% -$3.77M 0.77% 55
2024
Q1
$50.9M Buy
696,758
+37,324
+6% +$2.73M 0.68% 68
2023
Q4
$47.1M Buy
659,434
+191,870
+41% +$13.7M 0.69% 70
2023
Q3
$28M Buy
467,564
+1,154
+0.2% +$69.1K 0.46% 93
2023
Q2
$33.6M Buy
466,410
+11,321
+2% +$816K 0.52% 88
2023
Q1
$33.5M Buy
455,089
+673
+0.1% +$49.5K 0.56% 85
2022
Q4
$30.7M Sell
454,416
-269,720
-37% -$18.2M 0.56% 83
2022
Q3
$38.9M Sell
724,136
-2,943
-0.4% -$158K 0.74% 62
2022
Q2
$40.5M Buy
727,079
+57,554
+9% +$3.2M 0.75% 63
2022
Q1
$47M Buy
669,525
+10,117
+2% +$710K 0.69% 71
2021
Q4
$63.5M Buy
659,408
+1,915
+0.3% +$185K 0.82% 45
2021
Q3
$57.1M Buy
657,493
+74,974
+13% +$6.52M 0.78% 53
2021
Q2
$47.7M Sell
582,519
-11,889
-2% -$973K 0.65% 71
2021
Q1
$56.5M Sell
594,408
-339,009
-36% -$32.2M 0.82% 52
2020
Q4
$57.9M Sell
933,417
-19,746
-2% -$1.23M 0.86% 49
2020
Q3
$56.7M Sell
953,163
-46,973
-5% -$2.79M 1% 34
2020
Q2
$69.8M Buy
1,000,136
+70,997
+8% +$4.95M 1.26% 14
2020
Q1
$42.2M Buy
929,139
+114,655
+14% +$5.2M 1.02% 35
2019
Q4
$53M Sell
814,484
-5,098
-0.6% -$332K 1% 40
2019
Q3
$50.9M Buy
819,582
+110,756
+16% +$6.88M 1.02% 34
2019
Q2
$50.5M Buy
708,826
+26,519
+4% +$1.89M 0.96% 34
2019
Q1
$53.5M Buy
682,307
+27,730
+4% +$2.17M 1.09% 25
2018
Q4
$55.4M Buy
654,577
+41,537
+7% +$3.52M 1.31% 10
2018
Q3
$105M Sell
613,040
-53,553
-8% -$9.17M 1.94% 1
2018
Q2
$86.5M Sell
666,593
-14,777
-2% -$1.92M 1.74% 2
2018
Q1
$70.2M Sell
681,370
-7,494
-1% -$772K 1.52% 6
2017
Q4
$58.8M Sell
688,864
-34,454
-5% -$2.94M 1.34% 10
2017
Q3
$61.4M Buy
723,318
+4,728
+0.7% +$402K 1.42% 10
2017
Q2
$54.4M Sell
718,590
-322
-0% -$24.4K 1.31% 11
2017
Q1
$47.5M Buy
718,912
+53,130
+8% +$3.51M 1.17% 19
2016
Q4
$42.2M Buy
665,782
+42,055
+7% +$2.67M 1.18% 21
2016
Q3
$39.7M Buy
623,727
+49,100
+9% +$3.13M 1.18% 20
2016
Q2
$42.8M Sell
574,627
-44,557
-7% -$3.32M 1.4% 10
2016
Q1
$41.4M Sell
619,184
-4,861
-0.8% -$325K 1.45% 7
2015
Q4
$42.2M Sell
624,045
-12,750
-2% -$862K 1.49% 7
2015
Q3
$34M Sell
636,795
-45,793
-7% -$2.45M 1.2% 22
2015
Q2
$43M Sell
682,588
-43,457
-6% -$2.74M 1.27% 15
2015
Q1
$34.9M Buy
726,045
+5,381
+0.7% +$259K 1.04% 29
2014
Q4
$23.9M Sell
720,664
-28,915
-4% -$960K 0.71% 56
2014
Q3
$22M Buy
749,579
+229,728
+44% +$6.73M 0.66% 59
2014
Q2
$20.2M Buy
519,851
+56,698
+12% +$2.2M 0.62% 63
2014
Q1
$19.4M Buy
463,153
+100,354
+28% +$4.21M 0.59% 68
2013
Q4
$11.9M Buy
362,799
+60,000
+20% +$1.97M 0.4% 104
2013
Q3
$8.18M Buy
+302,799
New +$8.18M 0.28% 118